skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:038870/0160   Pages: 28
Recorded: 06/03/2016
Attorney Dkt #:13720.105153
Conveyance: ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Total properties: 38
1
Patent #:
5183462
Issue Dt:
02/02/1993
Application #:
07570395
Filing Dt:
08/21/1990
Title:
CONTROLLED ADMINISTRATION OF CHEMODENERVATING PHARMACEUTICALS
2
Patent #:
5298019
Issue Dt:
03/29/1994
Application #:
08004090
Filing Dt:
01/13/1993
Title:
CONTROLLED ADMINISTRATION OF CHEMODENERVATING PHARMACEUTICALS
3
Patent #:
5401243
Issue Dt:
03/28/1995
Application #:
08046097
Filing Dt:
04/12/1993
Title:
CONTROLLED ADMINISTRATION OF CHEMODENERVATING PHARMACEUTICALS
4
Patent #:
5696077
Issue Dt:
12/09/1997
Application #:
08316820
Filing Dt:
10/03/1994
Title:
PHARMACEUTICAL COMPOSITION CONTAINING BOTULINUM B COMPLEX
5
Patent #:
7537773
Issue Dt:
05/26/2009
Application #:
09382837
Filing Dt:
08/25/1999
Title:
CHEMODENERVATING PHARMACEUTICAL AS ANTI-INFLAMMATORY AGENT
6
Patent #:
6429189
Issue Dt:
08/06/2002
Application #:
09458784
Filing Dt:
12/10/1999
Title:
CYTOTOXIN (NON-NEUROTOXIN) FOR THE TREATMENT OF HUMAN HEADACHE DISORDERS AND INFLAMMATORY DISEASES
7
Patent #:
NONE
Issue Dt:
Application #:
10040830
Filing Dt:
01/08/2002
Publication #:
US20020192239
Pub Dt:
12/19/2002
Title:
Use of botulinum toxin for the treatment of chronic facial pain
8
Patent #:
NONE
Issue Dt:
Application #:
10212657
Filing Dt:
08/05/2002
Publication #:
US20020187164
Pub Dt:
12/12/2002
Title:
Cytotoxin (non-neurotoxin) for the treatment of human headache disorders and inflammatory diseases
9
Patent #:
7459164
Issue Dt:
12/02/2008
Application #:
10446562
Filing Dt:
05/28/2003
Publication #:
US20040037853
Pub Dt:
02/26/2004
Title:
COMPOSITION FOR THERAPEUTIC AND COSMETIC BOTULINUM TOXIN
10
Patent #:
7491403
Issue Dt:
02/17/2009
Application #:
10740755
Filing Dt:
12/22/2003
Publication #:
US20040151741
Pub Dt:
08/05/2004
Title:
PHARMACEUTICAL BOTULINUM TOXIN COMPOSITIONS
11
Patent #:
7335367
Issue Dt:
02/26/2008
Application #:
10793739
Filing Dt:
03/08/2004
Publication #:
US20040175400
Pub Dt:
09/09/2004
Title:
TREATMENT OF CHRONIC CHALAZION AND HORDEOLUM WITH BOTULINUM TOXIN
12
Patent #:
7670608
Issue Dt:
03/02/2010
Application #:
10793740
Filing Dt:
03/08/2004
Publication #:
US20040175390
Pub Dt:
09/09/2004
Title:
SELECTION OF PATIENTS WITH INCREASED RESPONSIVENESS TO BOTULINUM TOXIN
13
Patent #:
8691769
Issue Dt:
04/08/2014
Application #:
10793964
Filing Dt:
03/08/2004
Publication #:
US20040247606
Pub Dt:
12/09/2004
Title:
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin injections
14
Patent #:
7270826
Issue Dt:
09/18/2007
Application #:
11028600
Filing Dt:
01/05/2005
Publication #:
US20050208075
Pub Dt:
09/22/2005
Title:
METHODS OF USING BOTULINUM TOXIN FOR THE TREATMENT OF HYPERVOLEMIC LIP DEFORMITY (LIP ECTROPION)
15
Patent #:
8192979
Issue Dt:
06/05/2012
Application #:
11046721
Filing Dt:
02/01/2005
Publication #:
US20060147471
Pub Dt:
07/06/2006
Title:
COMPOSITIONS, METHODS AND DEVICES FOR PREPARING LESS PAINFUL BOTULINUM TOXIN FORMULATIONS
16
Patent #:
7691394
Issue Dt:
04/06/2010
Application #:
11111951
Filing Dt:
04/22/2005
Publication #:
US20060182767
Pub Dt:
08/17/2006
Title:
HIGH-POTENCY BOTULINUM TOXIN FORMULATIONS
17
Patent #:
8926991
Issue Dt:
01/06/2015
Application #:
11447984
Filing Dt:
06/07/2006
Publication #:
US20070009555
Pub Dt:
01/11/2007
Title:
BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT
18
Patent #:
NONE
Issue Dt:
Application #:
11505356
Filing Dt:
08/17/2006
Publication #:
US20100278867
Pub Dt:
11/04/2010
Title:
Use of botulinum toxin for the treatment of chronic facial pain
19
Patent #:
8580745
Issue Dt:
11/12/2013
Application #:
11709059
Filing Dt:
02/22/2007
Publication #:
US20110172161
Pub Dt:
07/14/2011
Title:
Composition for therapeutic and cosmetic botulinum toxin
20
Patent #:
7943152
Issue Dt:
05/17/2011
Application #:
12010183
Filing Dt:
01/22/2008
Publication #:
US20080118533
Pub Dt:
05/22/2008
Title:
TREATMENT OF CHRONIC CHALAZION AND HORDEOLUM WITH BOTULINUM TOXIN
21
Patent #:
8241640
Issue Dt:
08/14/2012
Application #:
12073245
Filing Dt:
03/03/2008
Publication #:
US20110293663
Pub Dt:
12/01/2011
Title:
PHARMACEUTICAL BOTULINUM TOXIN COMPOSITIONS
22
Patent #:
NONE
Issue Dt:
Application #:
12083058
Filing Dt:
08/03/2009
Publication #:
US20090324647
Pub Dt:
12/31/2009
Title:
Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use
23
Patent #:
9375476
Issue Dt:
Application #:
12318572
Filing Dt:
12/31/2008
Publication #:
US20090148476
Pub Dt:
06/11/2009
Title:
Anti-Inflammatory Topical Botulinum Toxin Composition
24
Patent #:
8679486
Issue Dt:
03/25/2014
Application #:
12662186
Filing Dt:
04/05/2010
Publication #:
US20100279945
Pub Dt:
11/04/2010
Title:
HIGH-POTENCY BOTULINUM TOXIN FORMULATIONS
25
Patent #:
9066851
Issue Dt:
06/30/2015
Application #:
13132855
Filing Dt:
10/28/2011
Publication #:
US20120039862
Pub Dt:
02/16/2012
Title:
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
26
Patent #:
9393291
Issue Dt:
07/19/2016
Application #:
13862206
Filing Dt:
04/12/2013
Publication #:
US20140105883
Pub Dt:
04/17/2014
Title:
USE OF BOTULINUM TOXIN FOR THE TREATMENT OF CEREBROVASCULAR DISEASE, RENOVASCULAR AND RETINOVASCULAR CIRCULATORY BEDS
27
Patent #:
NONE
Issue Dt:
Application #:
14225011
Filing Dt:
03/25/2014
Publication #:
US20140315820
Pub Dt:
10/23/2014
Title:
High-Potency Botulinum Toxin Formulations
28
Patent #:
NONE
Issue Dt:
Application #:
14464740
Filing Dt:
08/21/2014
Publication #:
US20170319667
Pub Dt:
11/09/2017
Title:
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
29
Patent #:
NONE
Issue Dt:
Application #:
14552755
Filing Dt:
11/25/2014
Publication #:
US20170333537
Pub Dt:
11/23/2017
Title:
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
30
Patent #:
NONE
Issue Dt:
Application #:
14555870
Filing Dt:
11/28/2014
Publication #:
US20150086533
Pub Dt:
03/26/2015
Title:
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
31
Patent #:
NONE
Issue Dt:
Application #:
14573659
Filing Dt:
12/17/2014
Publication #:
US20170143807
Pub Dt:
05/25/2017
Title:
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
32
Patent #:
NONE
Issue Dt:
Application #:
14722990
Filing Dt:
05/27/2015
Publication #:
US20150258183
Pub Dt:
09/17/2015
Title:
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
33
Patent #:
NONE
Issue Dt:
Application #:
14753917
Filing Dt:
06/29/2015
Publication #:
US20150297688
Pub Dt:
10/22/2015
Title:
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
34
Patent #:
9950042
Issue Dt:
04/24/2018
Application #:
14754268
Filing Dt:
06/29/2015
Publication #:
US20150297684
Pub Dt:
10/22/2015
Title:
Extended Length Botulinum Toxin Formulation for Human or Mammalian Use
35
Patent #:
9901627
Issue Dt:
02/27/2018
Application #:
14803574
Filing Dt:
07/20/2015
Publication #:
US20160015794
Pub Dt:
01/21/2016
Title:
Topical Ocular Preparation of Botulinum Toxin for Use in Ocular Surface Disease
36
Patent #:
10441641
Issue Dt:
10/15/2019
Application #:
14852990
Filing Dt:
09/14/2015
Publication #:
US20170252415
Pub Dt:
09/07/2017
Title:
Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
37
Patent #:
10857215
Issue Dt:
12/08/2020
Application #:
14931329
Filing Dt:
11/03/2015
Publication #:
US20160051645
Pub Dt:
02/25/2016
Title:
USE OF BOTULINUM TOXIN FOR THE TREATMENT OF CEREBROVASCULAR DISEASE, RENOVASCULAR AND RETINOVASCULAR CIRCULATORY BEDS
38
Patent #:
NONE
Issue Dt:
Application #:
14966759
Filing Dt:
12/11/2015
Publication #:
US20160095908
Pub Dt:
04/07/2016
Title:
Botulinum Toxin for Primary Disorders of Mood and Affect using Neurotransmitter CNS imaging Studies
Assignor
1
BOTULINUM TOXIN RESEARCH ASSOCIATES, INC.
Exec Dt:
06/02/2016
Assignee
1
REVANCE THERAPEUTICS, INC.
7555 GATEWAY BOULEVARD
NEWARK, CALIFORNIA 94560
Correspondence name and address
KING & SPALDING LLP
1185 AVENUE OF THE AMERICAS
NEW YORK, NY 10036

Search Results as of: 05/30/2024 09:07 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT